Primary lymphedema is rare, affecting about 1 in 100,000 people
Patients across North Florida are exploring tirzepatide as a non-surgical option for medically supervised weight management, including those seeking treatment in Jacksonville, Tallahassee, Gainesville, Pensacola, Daytona Beach, Ocala, and surrounding North Florida communities
GLP-1 receptor agonists and cardiovascular outcome trials: An update
CJC-1295 should be taken about twice a week
On the negative side of things, the FDA updated the label for Ozempic with a warning about intestinal blockages after multiple reports of the rare but severe side effect
prescribers can evaluate whether dosage timing or an alternative therapy would reduce gastric or metabolic contributors